There is an unmet medical need for endometrial cancer patients with mismatch-repair proficient disease. Here, the authors report the primary analysis of the FRUSICA-1 phase Ib/II trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results